IDOG - ETF AI Analysis

Top Page

ALPS International Sector Dividend Dogs ETF (IDOG)

Rating:56Neutral

Price Target:―

The ALPS International Sector Dividend Dogs ETF (IDOG) has a balanced overall rating, reflecting a mix of strong and weaker holdings. GlaxoSmithKline (GSK) stands out as a key contributor due to its solid financial performance, favorable valuation metrics, and positive technical indicators, making it a compelling investment in the drug manufacturing sector. On the other hand, Kering SA's declining revenues and valuation concerns may have slightly held back the ETF's rating. Investors should note the ETF's exposure to diverse sectors and regions, which helps mitigate risks but may also introduce variability in performance.

Positive Factors

Strong Geographic Diversification

The ETF invests across multiple countries, reducing reliance on any single economy and offering global exposure.

Healthy Year-to-Date Performance

The fund has delivered strong returns so far this year, indicating solid momentum.

Reasonable Expense Ratio

With a 0.5% expense ratio, the ETF is competitively priced compared to many international funds.

Negative Factors

Underperforming Holdings

Some top holdings, like Stellantis and Ericsson, have lagged in performance, which could drag on overall returns.

Sector Imbalance

The ETF has relatively low exposure to high-growth sectors like Technology and Energy, which may limit upside potential.

Small U.S. Allocation

The fund has minimal exposure to U.S. companies, which could miss out on opportunities in the world's largest economy.

IDOG vs. SPDR S&P 500 ETF (SPY)

AUM434.59M

RegionDeveloped Markets

Expense Ratio0.50%

Beta0.53

IssuerALPS

Inception DateJun 27, 2013

Dividend Yield4.26%

Asset ClassEquity

Index TrackedS-Network International Sector Dividend Dogs Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume32,147

30 Day Avg. Volume26,340

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

43.53

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering50

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IDOG Summary

The ALPS International Sector Dividend Dogs ETF (IDOG) is an investment fund that focuses on large companies worldwide that pay high dividends. It follows the S-Network International Sector Dividend Dogs Index, which picks the top five dividend-paying stocks from ten different industries, ensuring a mix of sectors and global exposure. Some of its holdings include well-known companies like Rio Tinto and Stellantis. This ETF is a good option for investors seeking income through dividends and diversification across international markets. However, since it invests globally, its performance can be affected by currency fluctuations and economic conditions in other countries.

How much will it cost me?The ALPS International Sector Dividend Dogs ETF (IDOG) has an expense ratio of 0.50%, which means you’ll pay $5 per year for every $1,000 invested. This expense ratio is higher than average for ETFs because it uses an active strategy to select high-dividend stocks across multiple sectors globally. Active management typically involves more research and trading, which increases costs.

What would affect this ETF?The ALPS International Sector Dividend Dogs ETF (IDOG) could benefit from global economic growth, particularly in developed markets outside the U.S., which may boost large-cap companies across sectors like Industrials and Consumer Cyclical. However, risks such as rising interest rates or economic slowdowns in key regions could negatively impact dividend-paying stocks and sectors like Financials and Utilities. Additionally, currency fluctuations in international markets may influence returns for U.S.-based investors.

IDOG Top 10 Holdings

The ALPS International Sector Dividend Dogs ETF (IDOG) is leaning on global dividend powerhouses to drive returns, with healthcare names like Roche Holding and GlaxoSmithKline showing steady gains thanks to strong pipelines and solid financials. Japan Tobacco is also rising, buoyed by product launches and acquisitions, while Rio Tinto’s performance has been steady, supported by attractive valuations. However, luxury giant Kering SA is losing steam, with mixed signals from declining revenues. The fund’s broad sector diversification and focus on developed markets ex-U.S. provide stability, though healthcare and consumer defensive stocks are key drivers.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
	―	2.65%	$11.46M	―	―	―
KER	Kering SA	2.41%	$10.41M	€38.37B	34.02%	62 Neutral
STLA	Stellantis	2.34%	$10.11M	$44.05B	-9.27%	63 Neutral
RIO	Rio Tinto	2.33%	$10.05M	£98.02B	23.40%	82 Outperform
ROG	Roche Holding AG	2.27%	$9.82M	CHF253.59B	44.17%	73 Outperform
ERIC.B	Telefonaktiebolaget LM Ericsson Class B	2.27%	$9.82M	kr298.79B	2.18%	72 Outperform
DHL	DHL Group	2.27%	$9.80M	€50.91B	38.08%	76 Outperform
FMG	Fortescue Metals Group Ltd	2.24%	$9.68M	AU$69.09B	37.56%	76 Outperform
CAP	Capgemini SE	2.23%	$9.63M	€25.27B	-4.86%	74 Outperform
GSK	GlaxoSmithKline	2.23%	$9.63M	£73.98B	37.10%	77 Outperform

IDOG Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

37.14

Positive

100DMA

36.16

Positive

200DMA

34.07

Positive

Market Momentum

MACD

0.41

Negative

RSI

66.25

Neutral

STOCH

42.35

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IDOG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.96, equal to the 50-day MA of 37.14, and equal to the 200-day MA of 34.07, indicating a bullish trend. The MACD of 0.41 indicates Negative momentum. The RSI at 66.25 is Neutral, neither overbought nor oversold. The STOCH value of 42.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IDOG.

IDOG Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
IDOG	―	―	$434.59M	0.50%	―
AVIV	―	―	$997.80M	0.25%	―
CVIE	―	―	$277.49M	0.18%	―
TPIF	―	―	$190.85M	0.62%	―
PTIN	―	―	$165.83M	0.67%	―
TLCI	―	―	$103.69M	0.37%	―

Performance Comparison

IDOG

ALPS International Sector Dividend Dogs ETF

38.57

10.99

39.85%

AVIV

Avantis International Large Cap Value ETF

―

CVIE

Calvert International Responsible Index ETF

―

TPIF

Timothy Plan International ETF

―

PTIN

Pacer Trendpilot International ETF

―

TLCI

Touchstone International Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents